Singapore to subsidize shingles vaccine starting in September

11/2/2025 12:10

Singapore will begin providing subsidies and allow individuals to use their personal medical savings for shingles vaccination, the Ministry of Health announced on Monday.



Starting from September 2025, eligible Singaporeans and permanent residents will be able to receive means-tested subsidies of up to 75 percent for Shingrix, the only vaccine currently approved by the Health Sciences Authority for shingles prevention, the ministry said in a statement.



As part of this initiative, seniors from the Pioneer Generation and the Merdeka Generation, two programs aimed at recognizing the contributions of these older generations to Singapore's early development, will receive additional subsidies for outpatient vaccinations.



Following the subsidies, citizens will pay between 75 and 300 Singapore dollars for a full course of Shingrix, which consists of two doses. Permanent residents will pay about 450 Singapore dollars per course.



From 2026 onwards, MediSave, the country's personal medical savings scheme, can be used to cover the costs of the vaccine after subsidies. MediSave allows individuals to save a portion of their income in a mandatory account for future medical expenses.